Search

everythinglearnresearchcommunity

for

Search:↓

People with mycosis fungoides/Sézary syndrome have a much lower quality of life.

The HAIR-Q is a reliable tool for assessing patient satisfaction with hair loss treatments.

The Italian version of a relationship scale was adapted for cancer patients, showing some differences from the original and suggesting its use could improve therapy and treatment adherence.

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

The document concludes that a new questionnaire to assess mental health in alopecia patients shows low rates of seeking mental health services and support groups.

Traumatic stress and alexithymia may contribute to alopecia areata.

The two-factor model fits better for Chinese patients' understanding of illness causes than the original four-factor model.

Hair transplant improved self-perception in hair loss patients, but some still remained overly focused on their hair appearance.

The Swedish Hairdex-S is a reliable tool for assessing quality of life in Alopecia Areata patients.

Symptom experience doesn't affect medication compliance in liver transplant patients.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in patients with Tourette syndrome.

The study created a 27-item measure to assess the impact of skin diseases.

Negative illness perceptions increase emotional distress, worsening OCD symptoms in alopecia areata patients.

The new measure helps understand the personal and emotional impact of hair loss in alopecia areata patients.

Many different biological, psychological, and social factors can cause sexual dysfunction in American women.

The Spanish HSS-29 scale effectively measures changes in life quality due to female-pattern hair loss.

WAA-QOL measures impact of hair loss on women's well-being.

Many skin patients also have mental health issues, and doctors should treat both together.

Lower illness acceptance is linked to more body dysmorphic disorder symptoms in patients with body modifications.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Some skin patients have body image issues linked to social difficulties but want psychological help.

PCOS causes sexual dysfunction, needing comprehensive treatment.

Post-SSRI sexual dysfunction syndrome was formally recognized in 2006, impacting clinical practice and research.

SRD5A2 gene variations affect PTSD symptoms differently in males and females.

Satoyoshi syndrome is likely an autoimmune disease.

Post-exposure syndromes are persistent conditions caused by past exposures, needing unique interventions.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.